Screening for Environmental Triggers in Recurrent Fever: A Comprehensive Clinical Review

Abstract

Recurrent fever syndromes present a diagnostic challenge in clinical practice, particularly when environmental triggers play a significant etiological role. This review synthesizes current evidence regarding the identification, mechanisms, and management of environmental factors implicated in recurrent fever episodes. Emphasis is placed on the importance of systematic screening, recent advances in diagnostic modalities, and practical guideline recommendations to enhance patient outcomes in both pediatric and adult populations.

Introduction

Recurrent fever is defined as the repeated occurrence of febrile episodes separated by at least one week of normal temperature. While monogenic periodic fever syndromes and infectious etiologies are well-recognized, environmental triggers are increasingly implicated, especially in cases lacking clear hereditary or infectious causes. Accurate identification of environmental factors is essential for targeted interventions, but screening strategies remain underutilized in routine clinical practice. This article reviews the epidemiology, pathophysiology, risk factors, clinical features, and diagnostic approaches to screening for environmental triggers in recurrent fever, with a focus on evidence-based management and emerging therapies.

Epidemiology / Disease Burden

Recurrent fever syndromes affect both pediatric and adult populations worldwide. Epidemiological studies estimate a prevalence of up to 2% in children and 1% in adults presenting to primary care with unexplained fever. Environmental triggers, such as allergen exposure, chemical irritants, and climate extremes, are increasingly identified as contributing factors, particularly in urbanized or industrial regions. Occupational exposures and socioeconomic factors also modulate disease burden, underscoring the need for tailored screening protocols in high-risk populations. Underdiagnosis remains a significant challenge, often resulting in inappropriate investigations and delayed management.

Pathophysiology

The pathogenesis of recurrent fever due to environmental triggers involves complex interplay between genetic predisposition, immune dysregulation, and direct or indirect environmental insults. Common mechanisms include activation of the innate immune system by airborne allergens (e.g., pollen, mold), volatile organic compounds, or particulate matter, leading to cytokine release and fever. Temperature extremes, such as heat waves, can directly affect thermoregulatory pathways and precipitate febrile episodes in susceptible individuals. Epigenetic modifications and altered microbiome profiles may further sensitize the host response to environmental stimuli, perpetuating a cycle of fever recurrence.

Risk Factors

Identifiable risk factors for environmentally triggered recurrent fevers include residence in areas with high air pollution, exposure to indoor allergens (such as dust mites, pet dander), occupational contact with chemicals or solvents, and poor ventilation in living or working spaces. Pre-existing atopic or inflammatory conditions, such as asthma or allergic rhinitis, augment susceptibility. Pediatric populations, the elderly, and immunocompromised individuals are at heightened risk due to immature or dysregulated immune responses. Socioeconomic deprivation, leading to suboptimal housing and increased exposure to environmental hazards, further compounds risk.

Clinical Features

Patients typically present with recurrent febrile episodes, often accompanied by constitutional symptoms such as malaise, myalgia, and fatigue. The temporal pattern may correlate with environmental exposures—seasonal changes, occupational shifts, or recent home renovations. Associated signs may include rashes, conjunctivitis, or respiratory symptoms, suggesting an allergic or irritant-mediated etiology. Careful history-taking is vital to distinguish environmentally triggered fevers from infectious, neoplastic, or autoimmune causes. Notably, symptom resolution upon removal from the suspected environment is a critical diagnostic clue.

Diagnosis

Diagnostic evaluation begins with a thorough clinical history and environmental exposure assessment, ideally using standardized questionnaires to identify potential triggers. Laboratory investigations are guided by clinical suspicion and may include inflammatory markers (CRP, ESR), allergen-specific IgE, and exclusion of infectious causes through cultures and serologies. Environmental sampling (air quality testing, allergen panels) and home or workplace assessments are increasingly employed. Genetic testing for hereditary fever syndromes may be warranted if environmental screening is inconclusive. Multidisciplinary collaboration with allergists, occupational medicine specialists, and environmental health professionals optimizes diagnostic accuracy.

Treatment & Management

Management involves both symptom control and mitigation of environmental exposures. Pharmacologic interventions include antipyretics, antihistamines, and corticosteroids for acute episodes, particularly when allergic mechanisms are implicated. Long-term management prioritizes identification and elimination of environmental triggers—improving indoor air quality, use of air purifiers, remediation of mold, and workplace modifications. Patient education and behavioral interventions, such as allergen avoidance and use of protective equipment, are essential. In refractory cases, immunomodulatory therapies may be considered under specialist supervision.

Recent Advances / Emerging Therapies

Recent advances include the development of portable air quality monitors and wearable biosensors that enable real-time tracking of environmental exposures and physiological responses. Novel biomarkers, such as microRNAs and exhaled breath condensate analytes, offer promise in differentiating environmentally triggered fevers from other etiologies. Digital health platforms facilitate longitudinal monitoring and patient engagement. Immunotherapy for specific allergens and biologic agents targeting key cytokines (e.g., anti-IL-1, anti-IL-6) are under investigation for severe or refractory cases, with early studies demonstrating efficacy in selected populations.

Guideline Recommendations

Recent guidelines from leading rheumatology, allergy, and infectious disease societies recommend systematic screening for environmental triggers in patients with unexplained recurrent fever, particularly in high-prevalence settings. Key recommendations include incorporation of detailed exposure history, use of validated assessment tools, and collaboration with environmental health experts. Guidelines emphasize the importance of ruling out infectious and hereditary causes before attributing fever to environmental factors. Ongoing surveillance and periodic re-evaluation are advised to ensure sustained remission and identify new or evolving triggers.

Conclusion

Screening for environmental triggers is an essential component in the evaluation and management of recurrent fever syndromes. Integration of structured environmental assessment, multidisciplinary collaboration, and patient-centered interventions can markedly improve diagnostic accuracy and patient outcomes. Continued research and technological innovation will further refine screening strategies and expand therapeutic options, ultimately reducing the burden of recurrent fever attributable to environmental factors in diverse clinical settings.